Fahrbach K - Search Results

1

Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancer.

Reckamp KL, Lin HM, Cranmer H, Wu Y, Zhang P, Walton LJ, Kay S, Cichewicz A, Neupane B, Fahrbach K, Popat S, Camidge DR. Reckamp KL, et al. Among authors: fahrbach k. Future Oncol. 2022 Jun;18(20):2499-2510. doi: 10.2217/fon-2022-0194. Epub 2022 May 24. Future Oncol. 2022. PMID: 35608148 Free article.

2

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis.

Popat S, Mellemgaard A, Fahrbach K, Martin A, Rizzo M, Kaiser R, Griebsch I, Reck M. Popat S, et al. Among authors: fahrbach k. Future Oncol. 2015;11(3):409-20. doi: 10.2217/fon.14.290. Epub 2014 Dec 5. Future Oncol. 2015. PMID: 25478720

3

Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis.

Deitelzweig S, Bergrath E, di Fusco M, Kang A, Savone M, Cappelleri JC, Russ C, Betts M, Cichewicz A, Schaible K, Tarpey J, Fahrbach K. Deitelzweig S, et al. Among authors: fahrbach k. Future Cardiol. 2022 May;18(5):393-405. doi: 10.2217/fca-2021-0120. Epub 2022 Apr 1. Future Cardiol. 2022. PMID: 35360925 Free article. Review.

4

Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.

Abogunrin S, Ashaye AO, Cappelleri JC, Clair AG, Fahrbach K, Ramaswamy K, Serfass L, Srinivas S, Thomaidou D, Zanotti G. Abogunrin S, et al. Among authors: fahrbach k. Future Oncol. 2019 Jun;15(18):2175-2190. doi: 10.2217/fon-2018-0858. Epub 2019 Apr 23. Future Oncol. 2019. PMID: 31010323 Free article.

5

Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis.

Burnett H, Fahrbach K, Cichewicz A, Jindal R, Tarpey J, Durand A, Di Domenico M, Reichelt A, Viljoen A. Burnett H, et al. Among authors: fahrbach k. Curr Med Res Opin. 2022 May;38(5):777-784. doi: 10.1080/03007995.2022.2049164. Epub 2022 Mar 20. Curr Med Res Opin. 2022. PMID: 35262430 Free article.

6

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.

Armstrong A, Fahrbach K, Leonardi C, Augustin M, Neupane B, Kazmierska P, Betts M, Freitag A, Kiri S, Taieb V, Slim M, Gomez NN, Warren RB. Armstrong A, et al. Among authors: fahrbach k. Dermatol Ther (Heidelb). 2022 Aug;12(8):1777-1792. doi: 10.1007/s13555-022-00760-8. Epub 2022 Jul 7. Dermatol Ther (Heidelb). 2022. PMID: 35798920 Free PMC article.

7

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis.

Fahrbach K, Sarri G, Phillippo DM, Neupane B, Martel SE, Kiri S, Reich K. Fahrbach K, et al. Dermatol Ther (Heidelb). 2021 Dec;11(6):1965-1998. doi: 10.1007/s13555-021-00602-z. Epub 2021 Sep 22. Dermatol Ther (Heidelb). 2021. PMID: 34549383 Free PMC article.

8

Meta-Regression of Herpes Zoster Incidence Worldwide.

Curran D, Callegaro A, Fahrbach K, Neupane B, Vroling H, van Oorschot D, Yawn BP. Curran D, et al. Among authors: fahrbach k. Infect Dis Ther. 2022 Feb;11(1):389-403. doi: 10.1007/s40121-021-00567-8. Epub 2021 Dec 7. Infect Dis Ther. 2022. PMID: 34874546 Free PMC article.

9

A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia.

Ashaye AO, Khankhel Z, Xu Y, Fahrbach K, Mokgokong R, Orme ME, Lang K, Cappelleri JC, Mamolo C. Ashaye AO, et al. Among authors: fahrbach k. Future Oncol. 2019 Feb;15(6):663-681. doi: 10.2217/fon-2018-0512. Epub 2018 Nov 19. Future Oncol. 2019. PMID: 30450960 Free article.

10

Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis.

Xu Y, Fahrbach K, Dorman E, Baculea S, Côté S, Sanden SV, Diels J. Xu Y, et al. Among authors: fahrbach k. J Comp Eff Res. 2018 May;7(5):421-441. doi: 10.2217/cer-2017-0086. Epub 2017 Dec 6. J Comp Eff Res. 2018. PMID: 29210593 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters